PIK3CA Mutational Status Assessment
NCT06706570 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-03-24
Summary
Evaluation of PIK3CA mutational status: a route towards a tailored diagnostic approach.
Conditions
- Breast Cancer Metastatic
Sponsors & Collaborators
-
European Institute of Oncology
lead OTHER
Principal Investigators
-
Nicola Fusco, MD · Istituto Europeo di Oncologia
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-06
- Primary Completion
- 2026-12-31
- Completion
- 2030-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
NCT04480814 ·Status: COMPLETED
-
Discordant HER2/Neu Status of Breast Cancer.
NCT01935739 ·Status: COMPLETED
-
Safety of Pregnancy in BRCA Mutated Breast Cancer Patients
NCT03673306 ·Status: COMPLETED
-
Integrated Testing Strategy for Simultaneous Detection of ESR-1 and gBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,
NCT06762483 ·Status: RECRUITING
-
Breast Cancer Detection in Breast Surgical Specimens With the Histolog Scanner, Slide-free Confocal Microscope
NCT04976556 ·Status: COMPLETED
-
Improving the Approach to and Management of the Older Metastatic Breast Cancer Patient
NCT03007641 ·Status: COMPLETED ·Phase: NA
-
Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone
NCT06321666 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality
NCT01024114 ·Status: WITHDRAWN
-
Prospective Observational Study for Breast Microcalcifications' Classification With Artificial Intelligence Techniques
NCT05767424 ·Status: ACTIVE_NOT_RECRUITING
-
MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer
NCT06247449 ·Status: RECRUITING ·Phase: NA
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 ·Status: COMPLETED
-
Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.
NCT06417801 ·Status: RECRUITING
-
Study of Metabolites Markers in Adjuvant Breast Cancer
NCT03367208 ·Status: COMPLETED
-
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas
NCT06805084 ·Status: ACTIVE_NOT_RECRUITING
-
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
NCT03709186 ·Status: COMPLETED
-
Imaging the Patterns of Breast Cancer Early Metastases
NCT02706964 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer and Its Relationship With the Microbiota
NCT03885648 ·Status: ACTIVE_NOT_RECRUITING
-
Discordant Hormonal Status of Breast Cancer.
NCT01943032 ·Status: COMPLETED
-
Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases
NCT06468124 ·Status: RECRUITING
-
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
NCT00276120 ·Status: COMPLETED
-
Evaluation of the DCIS Score for Decisions on Radiotherapy in Patients With Low/Intermediate Risk DCIS
NCT02766881 ·Status: COMPLETED
-
Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer
NCT06790264 ·Status: RECRUITING ·Phase: NA
-
Study Investigating the Role of Routine Screening and Molecular Characterisation of Brain Metastasis in the Management of High-risk Metastatic Breast Cancer
NCT06728150 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer
NCT01460186 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Prognostic Monitoring for Young Breast Cancer Patients
NCT04145986 ·Status: UNKNOWN